Drug · DIN 02522608
WEGOVY
SINGLE-DOSE PREFILLED PEN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since November 23, 2021.
- Drug Identification Number (DIN)
- 02522608
- Company (DIN owner)
- Novo Nordisk Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Semaglutide A10BJ06
- Class
- Human
- Record last updated
- October 5, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SEMAGLUTIDE | 2.4 MG | 0.75 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 23, 2021: NOC 27091New Drug Submission (NDS)
Other DINs named WEGOVY
- DIN 02528509 · Marketed
- DIN 02528517 · Marketed
- DIN 02528525 · Marketed
- DIN 02528533 · Marketed
- DIN 02528541 · Marketed
- DIN 02552698 · Marketed
- DIN 02522551 · Approved
- DIN 02522578 · Approved
- DIN 02522586 · Approved
- DIN 02522594 · Approved